Ahmed Abdelalim

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2020
Publications (10 Years): 3

Top Topics

Ejection Fraction

Multiple Sclerosis

Top Venues

Therapeutics and clinical risk management

Journal of pain research

Cairo University

Cairo University Kasr Alainy Faculty of Medicine (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Cairo University

Egypt

Professor :: Neurology

Cairo University Kasr Alainy Faculty of Medicine

Egypt

Assistant Professor

Cairo University Kasr Alainy Faculty of Medicine

Egypt

Lecturer :: Neurology

Cairo University Kasr Alainy Faculty of Medicine

Egypt

Assistant Lecturer :: Neurology

Cairo University Kasr Alainy Faculty of Medicine

Egypt

Resident :: Neurology

Education History

Cairo University Kasr Alainy Faculty of Medicine

Egypt

MSC :: Neurology

Publications

Alaa Elmazny, Sherif M Hamdy, Maged Abdel-Naseer, Nevin M Shalaby, Hatem S Shehata, Nirmeen A Kishk, Mona A F Nada, Husam S Mourad, Mohamed I Hegazy, Ahmed Abdelalim, Sandra M Ahmed, Ghada Hatem, Amr M Fouad, Hadel Mahmoud, Amr Hassan
Interferon-Beta-Induced Headache in Patients with Multiple Sclerosis: Frequency and Characterization. Journal of pain research 13 (2020)
Sherif M Hamdy, Maged Abdel Naseer, Hatem S Shehata, Amr Hassan, Alaa Elmazny, Nevin M Shalaby, Noha T Abokrysha, Nirmeen A Kishk, Mona A F Nada, Sandra M Ahmed, Mohamed I Hegazy, Doaa Mekkawy, Husam S Mourad, Ahmed Abdelalim, Thomas Berger
Managing Disease-Modifying Therapies and Breakthrough Activity in Multiple Sclerosis Patients During the COVID-19 Pandemic: Toward an Optimized Approach. Therapeutics and clinical risk management 16 (2020)
Sherif M Hamdy, Maged Abdel Naseer, Hatem S Shehata, Nevin M Shalaby, Amr Hassan, Alaa Elmazny, Ehab Shaker, Mona A F Nada, Sandra M Ahmed, Mohamed I Hegazy, Husam S Mourad, Ahmed Abdelalim, Rehab Magdy, Alshimaa S Othman, Doaa A Mekkawy, Nirmeen Adel Kishk
Management Strategies of Patients with Neuromyelitis Optica Spectrum Disorder During the COVID-19 Pandemic Era. Therapeutics and clinical risk management 16 (2020)